By Polypharma Technologies…
To get in touch with Polypharma Technologies & Sciences GmbH, simply fill out the form below.
Subscribe to Supplier
Polypharma Antacid medication dossiers
End-to-end services provided by Polypharma Technologies & Sciences GmbH (Polypharma) include support for development of antacid medicines used for symptom relief of heartburn and indigestion.
Polypharma possesses an extensive portfolio of drug development dossiers that cover the most effective natural antacid ingredients such as calcium carbonate, aluminium hydroxide and magnesium hydroxide, used in both human and veterinary medicine, as well as the stomach acid reducing compound pantoprazole and the gullet-lining agent sodium alginate.
These antacid dossiers can be used to empower potential producers seeking fast track ways to develop medicines to meet local market needs, particularly across Middle East and North Africa (MENA) markets.
Human medicine generic antacid medicines
Antacids medicines neutralise stomach acid in human and animal stomach to relieve indigestion and heartburn. They are normally developed in oral solid dose (OSD) form as tablets available OTC without prescription.
Antacid tablets are typically used to alleviate the symptoms of indigestion, heartburn, or gastro-oesophageal reflux disease (GORD). In addition they can be useful for treating the discomfort associated with stomach ulcers or inflammation.
Polypharma is able to supply generic antacid drug dossiers to enable production of generic alternatives to antacid brands such as Gaviscon (alginic acid), Pepto-Bismol (bismuth subsalicylate) or Alka-Seltzer (sodium bicarbonate).
Veterinary medicine antacids
Polypharma also offers its partners across the MENA region a portfolio of antacid formulations for veterinary medical applications, particularly based on best antacid compounds such as calcium carbonate, aluminium hydroxide and magnesium hydroxide. These are supported by high level of expertise and an array of pre-developed generic antacid drug dossiers covering many therapeutic classes for all animals.
Polypharma is also able to develop new antacid dossiers on request and after having carried out a specific feasibility study on the substance.